All Posts
A Delphi study of rescue and clinical subject matter experts on the extrication of patients following a motor vehicle collision.
23 Jun, 2022 | 10:19h | UTC
RCT: Weaning of maintenance immunosuppressive therapy in lupus nephritis.
23 Jun, 2022 | 10:18h | UTC
Many researchers say they’ll share data — but don’t.
23 Jun, 2022 | 10:13h | UTCMany researchers say they’ll share data — but don’t – Nature
M-A: Intravenous iron vs. oral iron vs. no iron with or without erythropoiesis‐ stimulating agents for cancer patients with anemia.
23 Jun, 2022 | 10:10h | UTC
RCT: Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y Gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity.
23 Jun, 2022 | 10:17h | UTCEffect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary on Twitter
10-year follow-up of the SLEEVEPASS RCT: both sleeve and gastric bypass resulted in good #weightloss. Reflux was more prevalent after sleeve. The incidence of #Barrettesophagus was much lower than in previous trials, and similar after both procedures. https://t.co/zRLzB6Nf7a
— JAMA Surgery (@JAMASurgery) June 22, 2022
Systematic Review: Interventions to improve water, sanitation, and hygiene for preventing soil‐transmitted helminth infection.
23 Jun, 2022 | 10:09h | UTC
Commentary from the author on Twitter
Our Cochrane review assessed the impact of WASH interventions on soil-transmitted helminths and found a 29% reduction in odds (95%CI 0.54 to 0.94). OR:0.86 amongst RCTs (95%CI 0.74 to 1.01). So. Many Meta-regressions! Moderate effect, yet important! https://t.co/t7s7kTYurx
— Matthew Freeman (@MatthewCFreeman) June 21, 2022
M-A: Early versus delayed complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.
23 Jun, 2022 | 10:11h | UTC
M-A: Effectiveness of pharmacological-based interventions, including education and prescribing strategies, to reduce subacute pain after total hip or knee arthroplasty.
23 Jun, 2022 | 10:04h | UTC
Commentary on Twitter
A systematic review of RCTs looking at effectiveness of pharmacological interventions to ⬇️ pain following total hip/knee arthroplasty. Interventions involving multimodal non-opioid analgesia & education show positive effects on ⬇️ pain intensity. https://t.co/t2majwzHPz pic.twitter.com/HoybWv2VFO
— Pain Medicine Journal (@PainMedJournal) March 31, 2022
RCTs: Risankizumab as induction therapy for Crohn’s disease.
23 Jun, 2022 | 10:02h | UTCRisankizumab as induction therapy for Crohn’s disease: results from the phase 3 ADVANCE and MOTIVATE induction trials – The Lancet (link to abstract – $ for full-text)
Related: Risankizumab as maintenance therapy for moderately to severely active Crohn’s disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
In patients with moderately to severely active Crohn's disease, risankizumab was effective and well tolerated as induction therapy, studies indicate.
Find out more: https://t.co/zg70L8RYka #crohnsdisease pic.twitter.com/9evGJAH8ke
— The Lancet (@TheLancet) June 1, 2022
Systematic Review: Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria.
23 Jun, 2022 | 10:07h | UTCPyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria – Cochrane Library
Summary: Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria – Cochrane Library
Cohort Study: Optimizing both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.
23 Jun, 2022 | 10:01h | UTCOptimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease – Annals of Rheumatic Diseases (link to abstract – $ for full-text)
Commentary: Low-dose glucocorticoids show no negative impact on BMD – medwire News
Commentary on Twitter
New and important study on #glucocorticoids and bone health in inflammatory rheumatic diseases. https://t.co/6XakxJO37y doses <5 mg/d together with low disease activity seem to have a low risk for #osteoporosis pic.twitter.com/Na5eMHLMS3
— Annals of the Rheumatic Diseases (@eular_ARD) June 12, 2022
Study Commentary: Simple tool identifies the people with diabetes most likely to develop foot ulcers.
23 Jun, 2022 | 10:00h | UTC
Phase II RCT: FLOT vs. FLOT/Trastuzumab/Pertuzumab perioperative therapy of human epidermal growth factor receptor 2–positive resectable esophagogastric adenocarcinoma.
23 Jun, 2022 | 09:58h | UTCFLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group – Journal of Clinical Oncology (link to abstract – $ for full-text)
Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts.
23 Jun, 2022 | 09:57h | UTC
5-year follow up of a RCT: Ruxolitinib versus best available therapy in inadequately controlled polycythemia vera without splenomegaly.
23 Jun, 2022 | 09:55h | UTCRuxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study – The Lancet Haematology (link to abstract – $ for full-text)
Original Study: Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study – The Lancet Oncology (link to abstract – $ for full-text)
Commentary on Twitter
NEW online—5-year follow up of RESPONSE-2, a randomised, phase 3b study, supports the use of ruxolitinib as a second-line therapy of choice for patients with inadequately controlled polycythaemia vera without splenomegaly #mpnsm https://t.co/yuENmcJv0P pic.twitter.com/aogZJ6gonW
— The Lancet Haematology (@TheLancetHaem) May 19, 2022
Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials.
23 Jun, 2022 | 09:54h | UTC
USPSTF Statement: The current evidence is insufficient to recommend vitamins for the prevention of cardiovascular disease or cancer.
22 Jun, 2022 | 12:21h | UTCEvidence Report and Systematic Review: Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer – JAMA
Patient Page: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer – JAMA
Editorial: Why Too Many Vitamins Feels Just About Right – JAMA Internal Medicine
Author Interview: Why Too Many Vitamins Feels Just About Right – JAMA
Commentary: Vitamins, Supplements Useless for Most People: Expert Panel – HealthDay
ASA and APSF statement on perioperative testing for the COVID-19 virus.
22 Jun, 2022 | 12:19h | UTCCommentary: ASA, APST Update Perioperative SARS-CoV-2 Testing Recommendations – HealthDay
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Computing for Audiology: Smartphone tympanometer for diagnosing middle ear disorders.
22 Jun, 2022 | 12:16h | UTCPerforming tympanometry using smartphones – Communications Medicine
News Release: Computing for Audiology: Smartphone tympanometer for diagnosing middle ear disorders – Bioengineering
Commentary on Twitter
A study in @CommsMedicine reports a smartphone attachment can be used to test the function of the middle ear and costs $28 for the materials, compared to traditional devices that can cost up to $5,000 to purchase. https://t.co/4zgBMdYFiY pic.twitter.com/SiTzoN0YVJ
— Nature Portfolio (@NaturePortfolio) June 16, 2022
RCT: Spinal anesthesia is associated with more pain and prescription analgesic use after hip surgery compared to general anesthesia.
22 Jun, 2022 | 12:11h | UTCStudy: Pain, Analgesic Use, and Patient Satisfaction With Spinal Versus General Anesthesia for Hip Fracture Surgery: A Randomized Clinical Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Original Publication: Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults – New England Journal of Medicine
Commentary: Spinal Anesthesia Tied to More Severe Pain After Hip Fracture Surgery – HealthDay
Related:
Cohort Study: Successful 10-second one-legged stance performance predicts survival in middle-aged and older individuals.
22 Jun, 2022 | 12:18h | UTCNews Release: Inability to stand on one leg in mid to later life linked to higher risk of death – University fo Bristol
Commentary on Twitter
🚨HOT OFF THE PRESS🔥
Can 10-second one-legged stance performance be used to predict survival in middle-aged and older adults?🤔
Find out more in the latest #OriginalResearch 📄
Thanks @cgsaraujo 👏
➡️ https://t.co/MIdmKqWfHT pic.twitter.com/2JB5pAoUhx
— British Journal of Sports Medicine (BJSM) (@BJSM_BMJ) June 21, 2022
Self-care management of bothersome symptoms as recommended by clinicians for patients with a chronic condition: A Delphi study.
22 Jun, 2022 | 12:13h | UTC
Cohort Study: Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.
22 Jun, 2022 | 12:07h | UTCCommentaries:
COVID-19 mRNA vaccination and myocarditis or pericarditis – The Lancet
Myocarditis and Pericarditis After the COVID-19 mRNA Vaccination – American College of Cardiology
Related:
Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Review: SARS-CoV-2 infection and COVID-19 vaccination in pregnancy.
22 Jun, 2022 | 12:09h | UTCSARS-CoV-2 infection and COVID-19 vaccination in pregnancy – Nature Reviews Immunology
Review: Sex differences in sequelae from COVID-19 infection and in long COVID syndrome.
22 Jun, 2022 | 12:06h | UTCCommentary: Women more likely to have long COVID, different symptom profile – CIDRAP


